The effect of age on the incorporation of newly synthesized aggrecan into the extracellular matrix of human articular cartilage was investigated. This property was measured in a pulse-chase explant culture system by determining the distribution of radiolabeled molecules ([ 35 S]sulfate-labeled) between a nondissociating extract (phosphate-buffered saline), which extracts mainly nonaggregated macromolecules, and a dissociating extract (4 M GnHCl) containing mainly aggrecan that was complexed in situ with hyaluronan. The rate of incorporation of aggrecan into aggregates was much slower in mature cartilage than in tissue obtained from younger individuals. Furthermore, autoradiography showed that in mature cartilage, newly synthesized aggrecan is not transported from the pericellular environment within the first 18 h of chase culture, whereas in immature cartilage, it moves into the intercellular space during the same period, i.e. aggrecan is processed in the extracellular space very differently in young and adult articular cartilage. Experiments were also performed to show that the interaction of link protein with newly synthesized aggrecan depends on the maturity of the G 1 domain of aggrecan. This investigation has shown that the extracellular aggregation of aggrecan in adult human articular cartilage involves a number of intermediate structures. These have not been identified in the very young cartilage obtained from laboratory animals or in porcine and bovine articular cartilage obtained from the abattoir.Aggrecan is one of the major macromolecules in the extracellular matrix of articular cartilage and endows the tissue with its characteristic water imbibing properties and its ability to undergo reversible compression. During normal aging of cartilage, aggrecan undergoes many posttranslational modifications to its protein core and to the number, size, and proportion of the chondroitin sulfate and keratan sulfate chains that are covalently associated with it (1). These events are mostly catabolic in nature and are a consequence of the relatively long resident time of aggrecan in the matrix (2). However, it is clear that a number of these age-related changes could only have come about by an altered anabolic response of the chondrocyte (3).A recent publication (3) has emphasized that the rate of aggrecan synthesis (sulfate incorporation) is dependent on the age of the specimen from which the tissue was obtained. However, the ability of the chondrocyte to make this molecule is only one part of the maintenance process; it also has to be assembled into aggregates in the extracellular matrix. This process involves the interaction of aggrecan with link protein(s) and hyaluronan, which are themselves under their own biosynthetic control, and the complex must then be deposited within the correct compartment of the tissue (4). Thus, extracellular assembly must be a rate-limiting step in the formation of a stable matrix. The speed at which aggregation happens is important for normal tissue homeostasis, but it would be part...